Identification of Functional Determinants of Response and Resistance to CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy of Chronic Lymphocytic Leukemia

被引：0
|
作者：
Fraietta, Joseph A.
Lacey, Simon F.
Orlando, Elena
Pruteanu, Julian
Gohil, Mercy
Wang, Yan
Boesteanu, Alina
OConnor, Roddy
Ambrose, David E.
Hwang, Wei-Ting
Wilcox, Nicholas
Bedoya, Felipe
Dorfmeier, Corin
Chen, Fang
Parakandi, Harit
Gupta, Minnal
Pequignot, Edward
Johnson, F. Brad
Kulikovskaya, Irina
Liu, Li
Lundh, Stefan M.
Xu, Jun
Davis, Megan M.
Young, Regina M.
Levine, Bruce L.
Siegel, Don L.
Huang, Alexander
Wherry, E. John
Zhou, Jing
Paczkowski, Patrick
Mackay, Sean
Brogdon, Jennifer
Bitter, Hans
Porter, David L.
June, Carl H.
Melenhorst, J. Joseph
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3181
引用
收藏
页数：2
相关论文
共 50 条
  • [21] RE: Epigenetic profiling and response to CD19 chimeric antigen receptor T-cell therapy in B-cell malignancies
    Lee, Hwan Young
    Yang, Soo-Bin
    Park, Mi Young
    Baek, Gyung Won
    Kang, Hyoung Jin
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (10): : 1231 - 1233
  • [22] Chimeric Antigen Receptor (CAR) T-Cell Therapy
    Pagel, John M.
    West, Howard
    JAMA ONCOLOGY, 2017, 3 (11) : 1595 - 1595
  • [23] Size Matters: Identification of Larger Size CD19 Positive Extracellular Vesicles in Chronic Lymphocytic Leukemia That Inhibit Chimeric Antigen Receptor T Cell Functions
    Forsman, Cynthia L.
    Sakemura, Reona
    Lucien-Matteoni, Fabrice
    Juarez-Diaz, Elizabeth
    Yang, Nan
    Cox, Michelle J.
    Sinha, Sutapa
    Hefazi, Mehrdad
    Schick, Kendall J.
    Boysen, Justin C.
    Parikh, Sameer A.
    Leong, Hon Sing
    Kay, Neil E.
    Kenderian, Saad S.
    BLOOD, 2018, 132
  • [24] Immune Therapy for Chronic Lymphocytic Leukemia Allogeneic Transplant, Chimeric Antigen Receptor T-cell Therapy, and Beyond
    Shadman, Mazyar
    Maloney, David G.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 35 (04) : 847 - 862
  • [25] Neuroimaging of complications arising after CD19 chimeric antigen receptor T-cell therapy: A review
    Pinto, Soniya N.
    Liu, Chia-Shang J.
    Nelson Jr, Marvin D.
    Bluml, Stefan
    Livingston, David
    Tamrazi, Benita
    JOURNAL OF NEUROIMAGING, 2023, 33 (05) : 703 - 715
  • [26] Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapy
    Boardman, Alexander P.
    Gutgarts, Victoria
    Flynn, Jessica R.
    Devlin, Sean M.
    Goldman, Adam
    Tomas, Ana Alarcon
    Fein, Joshua A.
    Slingerland, John B.
    Parascondola, Allison
    Lin, Richard J.
    Scordo, Michael
    Dahi, Parastoo B.
    Geralt, Sergio A.
    Palomba, M. Lia
    Salles, Gilles
    Nath, Karthik
    Walji, Moneeza
    Corona, Magdalena
    Park, Jae H.
    Shah, Gunjan L.
    Perales, Miguel-Angel
    Jaffer-Sathick, Insara
    Shouval, Roni
    HAEMATOLOGICA, 2025, 110 (03) : 651 - 664
  • [27] Myeloid leukemia switch as immune escape from CD19 chimeric antigen receptor (CAR) therapy
    Perna, Fabiana
    Sadelain, Michel
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S221 - S225
  • [28] Leukemia Cell Surface Antigen Modulation Induced By Dual CD19/CD20 Chimeric Antigen Receptor (CAR)-T Cells
    Schneider, Dina
    Xiong, Ying
    Wu, Darong
    Nolle, Volker
    Schmitz, Sarah
    Kaiser, Andrew
    Dropulic, Boro
    Orentas, Rimas
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S209 - S210
  • [29] CD19 Chimeric Antigen Receptor T Cell Therapy for the Treatment of B Cell Lineage Acute Lymphoblastic Leukemia
    Chen, Runzhe
    Song, Xiao-Tong
    Chen, Baoan
    DISCOVERY MEDICINE, 2015, 20 (110) : 185 - 190
  • [30] Chimeric antigen receptor-modified T cell therapy in chronic lymphocytic leukemia
    Zou, Yixin
    Xu, Wei
    Li, Jianyong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
12345